Literature DB >> 1803177

Breast cancer: early diagnosis of precursor lesions and clinically inapparent carcinoma by fine needle aspiration.

J A Linsk1.   

Abstract

Breast cancer death rate has remained stable at 26 per 100,000 for over 50 years. This control failure is due in large part to difficulty in early diagnosis. Combined clinical evaluation, mammography and fine needle aspiration (FNA) offer the best opportunity for early diagnosis. Non-directed FNA is a useful adjunctive technique and three illustrative cases are presented. Cancer evolves from proliferative epithelial disease of ducts and lobules. Atypical duct hyperplasia in association with family history is a pertinent marker for development of cancer. Identification of hyperplastic lesions traditionally occurs after surgical biopsy and histopathologic review. FNA demonstrates patterns of both duct hyperplasia and atypical duct hyperplasia. Ploidy studies of such smears offer the possibility of selecting precancerous lesions for extirpation. A combination of directed and undirected punctures and ploidy studies may yield early diagnosis of precancerous lesions.

Entities:  

Mesh:

Year:  1991        PMID: 1803177     DOI: 10.1007/BF02987176

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  29 in total

1.  Radiographic microcalcification and parenchymal patterns as indicators of histologic "high-risk" benign breast disease.

Authors:  S A Bartow; D R Pathak; F A Mettler
Journal:  Cancer       Date:  1990-10-15       Impact factor: 6.860

2.  Aspiration biopsy cytology, mammography and clinical exploration: a modern set up in diagnosis of tumors of the breast.

Authors:  G Kreuzer; E Boquoi
Journal:  Acta Cytol       Date:  1976 Jul-Aug       Impact factor: 2.319

3.  Aspiration biopsy in diagnosis of palpable lesions of the breast. Critical review of 3479 consecutive biopsies.

Authors:  S Franzén; J Zajicek
Journal:  Acta Radiol Ther Phys Biol       Date:  1968-08

Review 4.  New diagnostic, staging, and therapeutic aspects of early breast cancer.

Authors:  B Cady
Journal:  Cancer       Date:  1990-02-01       Impact factor: 6.860

Review 5.  Evaluation and management of breast abnormalities.

Authors:  D P Winchester
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

Review 6.  Anatomic markers of human premalignancy and risk of breast cancer.

Authors:  D L Page; W D Dupont
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

7.  Stereotactic fine-needle biopsy in 2594 mammographically detected non-palpable lesions.

Authors:  E Azavedo; G Svane; G Auer
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

8.  Ductal carcinoma-in-situ of the breast: fine-needle aspiration cytology of 12 cases.

Authors:  N Sneige; V A White; R L Katz; P Troncoso; H I Libshitz; G N Hortobagyi
Journal:  Diagn Cytopathol       Date:  1989       Impact factor: 1.582

9.  Risk factors for breast cancer in women with proliferative breast disease.

Authors:  W D Dupont; D L Page
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

10.  Cytologic identification of clinically occult proliferative breast disease in women with a family history of breast cancer.

Authors:  C J Marshall; G B Schumann; J H Ward; J M Riding; L Cannon-Albright; M Skolnick
Journal:  Am J Clin Pathol       Date:  1991-02       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.